Cargando…
Systemic coagulation parameters in mice after treatment with vascular targeting agents
BACKGROUND: Vascular targeting of malignant tumors has become a clinically validated new treatment approach with clear patient benefit. However clinical studies have also revealed that some types of vascular targeting agents (VTAs) are prone to coagulation system side effects. It is therefore essent...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1343590/ https://www.ncbi.nlm.nih.gov/pubmed/16336690 http://dx.doi.org/10.1186/1477-9560-3-21 |